- Home
- AKA vs NRXP Comparison
AKA vs NRXP Comparison
Compare AKA & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | NRXP |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 99.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AKA | NRXP |
|---|---|---|
| Price | $11.20 | $3.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $24.33 | ★ $38.25 |
| AVG Volume (30 Days) | 4.5K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | N/A |
| Revenue This Year | $6.14 | $2,547.84 |
| Revenue Next Year | $4.89 | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.44 | N/A |
| 52 Week Low | $8.42 | $1.65 |
| 52 Week High | $16.38 | $5.06 |
Technical Indicators
Market Signals| Indicator | AKA | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 70.52 | 52.28 |
| Support Level | $10.40 | $2.88 |
| Resistance Level | $11.42 | $4.20 |
| Average True Range (ATR) | 0.51 | 0.29 |
| MACD | 0.30 | -0.03 |
| Stochastic Oscillator | 91.41 | 71.36 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.